A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
The question of whether to partner with another company is critical to the long-term development…
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
New approaches to tame the immune system in the fight against cancer are getting us…
A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results…
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom…
Update (23/05/2018): Investors have fully subscribed Celyad's global offering of shares on NASDAQ and Euronext…
Celyad has reported clinical results showing the first time a patient has fully recovered from…
Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire…
European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’…
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…
Celyad has received Fast Track Designation from the FDA for C-Cure, a cell therapy aimed…